ArticleNature2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations BetweenWorld journal of oncology · 2026Article
- Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits.Frontiers in cell and developmental biology · 2026Review
- PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC.Journal for immunotherapy of cancer · 2025Observational
Corrections and comments
- Erratum for
Authors and funding
131 authors.
Ferdinandos SkoulidisDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. fskoulidis@mdanderson.org.ORCID http://orcid.org/0000-0002-4676-4503
Haniel A Araujo *Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Minh Truong Do *Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yu QianDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xin SunDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ana Galan CoboDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0988-1823
John T LeDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meagan MontesionFoundation Medicine, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9155-556X
Rachael PalmerPionyr Immunotherapeutics, South San Francisco, CA, USA.
Nadine JahchanPionyr Immunotherapeutics, South San Francisco, CA, USA.
Joseph M JuanD2G Oncology, Mountain View, CA, USA.
Chengyin MinTango Therapeutics, Boston, MA, USA.
Yi YuTango Therapeutics, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2223-337X
Xuewen PanTango Therapeutics, Boston, MA, USA.
Kathryn C ArbourDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Natalie VokesDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-3766-5335
Stephanie T SchmidtDepartment of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David MolkentineDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dwight H OwenDivision of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.
Regan MemmottDivision of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.
Pradnya D PatilTaussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Melina E MarmarelisDivision of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Mark M AwadLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Joseph C MurraySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6159-7814
Jessica A HellyerDepartment of Genetics, Stanford University, Stanford, CA, USA.
Justin F GainorMassachussetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8697-4081
Anastasios DimouDepartment of Oncology, Mayo Clinic, Rochester, MN, USA.
Christine M BestvinaDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Catherine A ShuColumbia University, New York, NY, USA.ORCID http://orcid.org/0000-0003-0765-7665
Jonathan W RiessUniversity of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Collin M BlakelyUniversity of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-8134-3651
Chad V PecotUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-5250-2999
Laura MezquitaDepartment of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.
Fabrizio TabbóOspedale Michele e Pietro Ferrero, Cuneo, Italy.ORCID http://orcid.org/0000-0001-8525-2992
Matthias SchefflerDepartment of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-9031-1368
Subba DigumarthyDepartment of Radiology, Massachussetts General Hospital, Boston, MA, USA.
Meghan J MooradianMassachussetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8289-8015
Adrian G SacherPrincess Margaret Cancer Centre, Toronto, Ontario, Canada.
Sally C M LauDepartment of Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA.
Andreas N SaltosDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Julia RotowLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Rocio Perez JohnsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Corinne LiuDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tyler StewartDivision of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.
Sarah B GoldbergYale School of Medicine, New Haven, CT, USA.
Jonathan KillamNorth Shore University Hospital, Manhasset, NY, USA.
Zenta WaltherDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.
Kurt SchalperDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5692-4833
Kurtis D DaviesDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Mark G WoodcockUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Valsamo AnagnostouSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9480-3047
Kristen A MarroneSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Patrick M FordeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6925-6344
Biagio RicciutiLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Deepti VenkatramanLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Eliezer M Van AllenLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amy L CummingsDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-0472-392X
Jonathan W GoldmanDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-4925-8243
Hiram ShaishColumbia University, New York, NY, USA.
Melanie KierIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Sharyn KatzDivision of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-9816-2291
Charu AggarwalDivision of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Ying NiTaussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-0338-5239
Joseph T AzokTaussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Jeremy SegalDepartment of Pathology, University of Chicago, Chicago, USA.
Lauren RitterhouseFoundation Medicine, Cambridge, MA, USA.
Joel W NealDepartment of Genetics, Stanford University, Stanford, CA, USA.
Ludovic LacroixInstitut Gustave Roussy, Villejuif, France.ORCID http://orcid.org/0000-0003-2535-1010
Yasir Y ElaminDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-5312-909X
Marcelo V NegraoDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8938-6699
Xiuning LeDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vincent K LamSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1319-2588
Whitney E LewisDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3839-8993
Haley N KempDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brett CarterDepartment of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jack A RothDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8955-1313
Stephen SwisherDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-3080-1920
Richard LeeDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0009-0007-1319-5280
Teng ZhouDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-7709-0265
Alissa PoteeteDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yifan KongDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tomohiro TakeharaDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alvaro Guimaraes PaulaDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Edwin R Parra CuentasDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9068-1636
Carmen BehrensDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ignacio I WistubaDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jianjun ZhangDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7872-3477
George R BlumenscheinDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Carl GayDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lauren A ByersDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0780-2677
Don L GibbonsDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-2362-3094
Anne TsaoDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Jack LeeDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5469-9214
Trever G BivonaUniversity of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5734-4128
D Ross CamidgeUniversity of Colorado Cancer Center, Denver, CO, USA.
Jhannelle E GrayDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Natasha B LeighlPrincess Margaret Cancer Centre, Toronto, Ontario, Canada.
Benjamin LevySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Julie R BrahmerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Marina C GarassinoDepartment of Medicine, University of Chicago, Chicago, IL, USA.
David R GandaraUniversity of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Edward B GaronDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-7077-8801
Naiyer A RizviSynthekine, Menlo Park, CA, USA.ORCID http://orcid.org/0000-0002-1134-7494
Giorgio Vittorio ScagliottiUniversity of Turin, Orbassano, Italy.ORCID http://orcid.org/0000-0001-6646-958X
Jürgen WolfDepartment of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
David PlanchardInstitut Gustave Roussy, Villejuif, France.
Benjamin BesseInstitut Gustave Roussy, Villejuif, France.ORCID http://orcid.org/0000-0001-5090-8189
Roy S HerbstYale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2535-5847
Heather A WakeleeDepartment of Genetics, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1136-980X
Nathan A PennellTaussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-1458-0064
Alice T ShawNovartis Institute for Biomedical Research, Cambridge, MA, USA.
Pasi A JänneLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7821-4928
David P CarboneDivision of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-3002-1921
Matthew D HellmannAstraZeneca, Gaithersburg, MD, USA.
Charles M RudinDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5204-3465
Lee AlbackerFoundation Medicine, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5070-1783
Helen MannAstraZeneca, Cambridge, UK.
Zhou ZhuAstraZeneca, Cambridge, UK.
Zhongwu LaiAstraZeneca, Cambridge, UK.
Ross StewartAstraZeneca, Cambridge, UK.
Solange PetersDepartment of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-0412-7143
Melissa L JohnsonSarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-9874-1314
Kwok K WongDivision of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6323-235X
Alan HuangTango Therapeutics, Boston, MA, USA.
Monte M WinslowD2G Oncology, Mountain View, CA, USA.ORCID http://orcid.org/0000-0002-5730-9573
Michael J RosenD2G Oncology, Mountain View, CA, USA.
Ian P WintersD2G Oncology, Mountain View, CA, USA.
Vassiliki A PapadimitrakopoulouPfizer, New York, NY, USA.
Tina CasconeDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3008-5407
Philip JewsburyAstraZeneca, Cambridge, UK.
John V HeymachDepartment of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jheymach@mdanderson.org.ORCID http://orcid.org/0000-0001-9068-8942
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.